Revenue Breakdown
Composition ()
No data
Revenue Streams
Milestone Scientific Inc (MLSS) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Handpieces, accounting for 79.5% of total sales, equivalent to $1.85M. Other significant revenue streams include Instruments and Accessories. Understanding this composition is critical for investors evaluating how MLSS navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, Milestone Scientific Inc maintains a gross margin of 68.67%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -48.07%, while the net margin is -48.89%. These profitability ratios, combined with a Return on Equity (ROE) of -136.47%, provide a clear picture of how effectively MLSS converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, MLSS competes directly with industry leaders such as HBIO and ZJYL. With a market capitalization of $20.72M, it holds a significant position in the sector. When comparing efficiency, MLSS's gross margin of 68.67% stands against HBIO's 54.23% and ZJYL's 24.31%. Such benchmarking helps identify whether Milestone Scientific Inc is trading at a premium or discount relative to its financial performance.
